$10.49
0.01[0.10%]
At close: May 9
$10.49
0[0.00%]
After Hours: 5:35PM EDT
INmune Bio
(NASDAQ:INMB)INmune Bio Stock (NASDAQ:INMB), Earnings Estimates, EPS, and Revenue
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.610
Quarterly Revenue
$14K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$155K
Analyze the earnings history of INmune Bio using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio (INMB) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?
The Actual EPS was $-0.61, which missed the estimate of $-0.53.
What were INmune Bio’s (NASDAQ:INMB) revenues?
The Actual Revenue was $14K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.